AstraZeneca wins U.S. FDA approval for first-line use of lung cancer drug

Reuters India Thursday, 19 April 2018 ()
(Reuters) - AstraZeneca Plc said on Wednesday the U.S. Food and Drug Administration (FDA) has approved the 1st-line use of its lung cancer drug, Tagrisso.
0
shares